Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Progyny | Mind Blowing Facts

Under the Radar: Hunting Smart in the Alleyway of Value and Growth

One of the biggest challenges in investing is finding stocks that combine the best of both worlds: the long-term upside of growth and the downside protection of solid fundamentals. That is the space where I like to hunt in the alleyway between value and growth, where stocks trade cheaply not…

Insights into HealthEquity's Upcoming Earnings

HealthEquity (NASDAQ:HQY) is preparing to release its quarterly earnings on Monday, 2024-12-09. Here's a brief overview of what investors should keep in mind before the announcement.

The Latest Analyst Ratings For Progyny

The Latest Analyst Ratings For Progyny

Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Progyny (NASDAQ:PGNY) in the last three months.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

In their rush to offer fertility benefits, employers could be unwittingly creating a new inequity for LGTBQIA+ employees

Most fertility benefits policies exclude same-sex couples who are hoping to build their families (along with single parents by choice).

Employers expand reproductive health benefits amid tight labor market

A growing number of employers are expanding health coverage to in-vitro fertilization, surrogacy and other sometimes pricey fertility services in order to compete in the tight labor market amid heightened awareness of women's health.

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022

Looking Into Progyny's Return On Capital Employed

Pulled from Benzinga Pro data, Progyny (NASDAQ:PGNY) showed a loss in earnings since Q3, totaling $15.08 million. Sales, on the other hand, increased by 4.31% to $127.55 million during Q4.

inkl

Read news from The Economist, FT, and more,
with one subscription

Progyny: Q4 Earnings Insights

Progyny: Q4 Earnings Insights

Progyny (NASDAQ:PGNY) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Progyny beat estimated earnings by 275.0%, reporting an EPS of $0.15 versus an estimate of $0.04.

Progyny's Earnings: A Preview

Progyny's Earnings: A Preview

Progyny (NASDAQ:PGNY) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Progyny will report an earnings per share (EPS) of $0.04.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Electronic Arts

Truist Securities

Canaccord Genuity

Hims Hers Health

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

356,262 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play